Minerva Neurosciences Inc's Comment on Sales, Marketing and Customers
The company serves customers including recipients of federal funds, private institutions utilizing group purchasing organizations or formularies for drug discounts, government healthcare programs, and private payors. Its market segments include Medicare Part B and Medicare Part D products subject to rebates and the Medicare Drug Price Negotiation Program, which targets certain single-source drugs available for at least seven years. The company is influenced by state and federal legislation regulating pharmaceutical pricing, reimbursement, product access, marketing transparency, importation, and bulk purchasing. Legislation such as the Patient Protection and Affordable Care Act (ACA), the Health Care and Education Reconciliation Act of 2010, and related regulations have expanded health insurance access and introduced new requirements and taxes affecting the healthcare and pharmaceutical industries. The company’s operations involve entities including the Department of Health and Human Services (HHS) and Medicare.
Minerva Neurosciences Inc’s Comment on Sales, Marketing and Customers
The company serves customers including recipients of federal funds, private institutions utilizing group purchasing organizations or formularies for drug discounts, government healthcare programs, and private payors. Its market segments include Medicare Part B and Medicare Part D products subject to rebates and the Medicare Drug Price Negotiation Program, which targets certain single-source drugs available for at least seven years. The company is influenced by state and federal legislation regulating pharmaceutical pricing, reimbursement, product access, marketing transparency, importation, and bulk purchasing. Legislation such as the Patient Protection and Affordable Care Act (ACA), the Health Care and Education Reconciliation Act of 2010, and related regulations have expanded health insurance access and introduced new requirements and taxes affecting the healthcare and pharmaceutical industries. The company’s operations involve entities including the Department of Health and Human Services (HHS) and Medicare.
Sources:
Minerva Neurosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Minerva Neurosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Minerva Neurosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
